backgroundacut
otiti
media
aom
occur
complic
viral
upper
respiratori
tract
infect
young
children
aom
respiratori
virus
display
season
variat
object
examin
tempor
associ
circul
respiratori
virus
occurr
pediatr
ambulatori
care
visit
aom
methodsthi
retrospect
studi
includ
season
respiratori
viral
activ
utah
use
intermountain
healthcar
electron
medic
record
assess
commun
respiratori
viral
activ
via
laboratorybas
activ
surveil
identifi
children
year
outpati
visit
code
aom
assess
strength
associ
aom
individu
respiratori
virus
use
interrupt
time
seri
analys
resultsdur
studi
period
respiratori
viral
test
perform
posit
commonli
identifi
virus
rsv
rhinoviru
influenza
parainfluenza
human
metapneumoviru
adenoviru
aom
diagnos
ambulatori
visit
signific
associ
peak
activ
rsv
human
metapneumoviru
influenza
offic
visit
aom
adenoviru
parainfluenza
rhinoviru
associ
visit
aom
conclusionsseason
rsv
human
metapneumoviru
influenza
activ
tempor
associ
increas
diagnos
aom
among
children
find
support
role
individu
respiratori
virus
develop
aom
data
also
underscor
potenti
respiratori
viral
vaccin
reduc
burden
aom
acut
upper
respiratori
tract
infect
one
common
reason
medic
encount
hospit
childhood
upper
respiratori
tract
infect
episod
complic
acut
otiti
media
aom
common
reason
outpati
healthcar
visit
antibiot
prescrib
children
previou
studi
use
cultur
techniqu
report
isol
respiratori
virus
among
children
aom
demonstr
significantli
higher
risk
develop
aom
follow
infect
respiratori
syncyti
viru
rsv
influenza
viru
molecular
diagnost
method
enhanc
abil
detect
establish
emerg
pathogen
eg
human
metapneumoviru
respons
respiratori
tract
infect
establish
import
respiratori
virus
pediatr
respiratori
infect
aom
understand
role
respiratori
virus
develop
aom
challeng
individu
virus
may
differ
middl
ear
tropism
abil
caus
viral
bacteri
middl
ear
infect
howev
improv
understand
respiratori
virus
close
associ
develop
aom
may
use
clinic
evalu
children
upper
respiratori
tract
infect
develop
viral
vaccin
aom
prevent
object
examin
strength
associ
new
establish
respiratori
virus
aom
use
data
larg
healthcar
system
perform
retrospect
studi
respiratori
viral
activ
januari
decemb
year
utah
use
intermountain
system
intermountain
larg
verticallyintegr
nonprofit
healthcar
system
own
oper
hospit
ambulatori
care
clinic
utah
southern
idaho
includ
primari
children
medic
center
pcmc
tertiari
children
hospit
salt
lake
citi
ut
evalu
associ
respiratori
viral
activ
among
children
younger
year
ambulatori
care
visit
aom
defin
analyz
case
aom
utahresid
children
receiv
care
intermountain
facil
although
marketshar
data
outpati
visit
avail
approxim
pediatr
hospit
utah
resid
occur
intermountain
facil
proport
remain
stabl
throughout
studi
period
courtesi
jim
bradshaw
director
strateg
plan
intermountain
healthcar
salt
lake
citi
ut
test
adenoviru
influenza
b
virus
parainfluenza
virus
rsv
perform
use
direct
fluoresc
antibodi
dfa
enzym
immunoassay
eia
viral
cultur
pcrbase
assay
detect
adenoviru
influenza
b
parainfluenza
rsv
human
metapneumoviru
rhinoviru
respiratori
sampl
eg
nasopharyng
aspir
obtain
primarili
children
respiratori
symptom
emerg
depart
inpati
set
respiratori
specimen
test
purpos
isol
cohort
medic
treatment
addit
pcmc
respiratori
viral
test
recommend
febril
infant
younger
day
age
intermountain
facil
american
academi
pediatr
aap
publish
clinic
practic
guidelin
defin
diagnosi
aom
sign
middleear
effus
sign
symptom
middleear
inflamm
confirm
acut
onset
studi
aom
defin
base
bill
code
use
intern
classif
diseas
ninth
revis
code
intermountain
facil
share
electron
record
system
includ
demograph
clinic
microbiolog
financi
data
queri
system
case
aom
among
utah
children
younger
year
intermountain
facil
year
aomspecif
code
includ
acut
nonsuppur
serou
mucoid
sanguin
otiti
media
acut
suppur
otiti
media
without
spontan
ruptur
eardrum
previous
describ
zhou
et
al
calcul
absolut
number
code
aom
episod
frequenc
individu
respiratori
virus
identifi
utah
throughout
intermountain
system
data
tabul
increment
statist
analys
calcul
proport
posit
test
divid
number
individu
virus
identifi
week
number
viral
test
perform
correl
respiratori
viru
aom
explor
spearman
rank
correl
goal
control
autocorrel
time
seri
data
use
method
develop
box
jenkin
build
autoregress
integr
move
averag
arima
time
seri
model
account
season
period
pattern
aom
individu
respiratori
virus
model
differ
chang
one
week
next
rather
model
seri
final
model
also
compar
lag
time
detect
respiratori
virus
date
code
aom
diagnosi
week
statist
analys
perform
use
sa
softwar
sa
institut
cari
nc
statacorp
lp
colleg
station
tx
usa
season
pattern
circul
respiratori
virus
shown
figur
figur
studi
period
children
resid
utah
diagnos
aom
intermountain
facil
averag
aom
diagnos
per
year
largest
number
occur
season
aom
diagnos
exhibit
moder
season
visit
identifi
novemb
april
year
major
aom
visit
among
children
younger
year
age
strong
correl
observ
aom
visit
intermountain
facil
activ
individu
circul
respiratori
virus
aom
visit
strongli
correl
isol
rsv
p
human
metapneumoviru
p
found
statist
signific
weaker
correl
aom
influenza
p
influenza
b
p
adenoviru
p
rhinoviru
p
correl
aom
time
lag
week
although
weaker
remain
signific
firstord
autoregress
integr
move
averag
arima
model
construct
appropri
correct
autocorrel
timeseri
data
associ
longer
statist
signific
number
respiratori
virus
tabl
howev
rsv
human
metapneumoviru
remain
significantli
associ
aom
week
p
week
p
strongest
associ
observ
lag
time
week
p
week
p
respect
strength
time
associ
similar
among
children
year
year
age
weaker
associ
found
influenza
vari
age
among
children
younger
year
associ
influenza
aom
strongest
without
lag
howev
among
children
year
age
strongest
associ
found
week
week
weak
associ
also
observ
influenza
b
week
adenoviru
parainfluenza
rhinoviru
associ
aom
visit
model
time
lag
time
week
respiratori
viral
infect
longbeen
implic
pathogenesi
aom
howev
contribut
influenc
specif
respiratori
virus
develop
aom
well
understood
populationbas
ecolog
studi
demonstr
tempor
associ
rsv
human
metapneumoviru
influenza
activ
larg
healthcar
system
aom
measur
code
aom
clinic
discharg
contrast
observ
associ
adenoviru
parainfluenza
rhinoviru
activ
health
care
visit
aom
aom
common
caus
health
care
visit
among
children
unit
state
children
experienc
least
one
episod
aom
year
age
unit
state
direct
indirect
medic
expenditur
aomrel
healthcar
visit
antibiot
prescript
estim
billion
age
group
aom
often
regard
bacteri
infect
primari
indic
million
antibiot
prescript
annual
among
children
younger
year
bacteria
identifi
middl
ear
fluid
sampl
children
aom
howev
newer
molecular
detect
method
increas
detect
respiratori
virusesalon
combin
bacteria
middl
ear
fluid
children
aom
ruohola
et
al
evalu
etiolog
aom
among
children
tympanostomi
tube
identifi
virus
case
moreov
detect
viral
bacteri
coinfect
children
aom
risk
develop
aom
follow
viral
upper
respiratori
tract
infect
appear
vari
viru
assess
contribut
individu
respiratori
virus
difficult
primarili
due
differ
methodolog
ruusaken
et
al
use
respiratori
viral
antigen
test
nasopharyng
specimen
note
signific
correl
aom
rsv
studi
aom
develop
children
rsv
infect
compar
influenza
infect
lower
rate
respiratori
virus
anoth
studi
henderson
et
al
test
nasopharyng
specimen
viral
cultur
report
strong
associ
rsv
influenza
b
adenoviru
parainfluenza
aom
aom
develop
rsv
posit
children
moreov
found
rhinoviru
outbreak
either
preced
coincid
peak
aom
diagnos
studi
use
combin
antigen
detect
viral
cultur
pcr
respiratori
viral
detect
found
result
similar
sever
way
previou
studi
observ
strong
tempor
associ
aom
rsv
activ
addit
effect
rsv
also
prolong
lag
period
extend
past
week
also
note
signific
associ
aom
influenza
viru
similar
previou
studi
dataset
effect
influenza
aom
vari
age
lag
influenza
activ
aom
among
young
children
year
associ
began
week
older
children
year
old
believ
lag
reflect
risk
develop
aom
among
individu
rather
may
reflect
epidemiolog
impact
respiratori
virus
popul
level
reason
differenti
effect
influenza
aom
unknown
need
investig
studi
one
first
demonstr
strong
prolong
associ
aom
human
metapneumoviru
best
fit
achiev
use
lag
period
week
week
strength
associ
compar
rsv
role
human
metapneumoviru
aom
well
defin
boivin
et
al
report
approxim
patient
admit
human
metapneumoviru
infect
display
otiti
symptom
use
pcr
william
et
al
evalu
viral
cultureneg
nasal
wash
middl
ear
fluid
specimen
children
aom
detect
human
metapneumoviru
nasal
wash
sampl
anoth
studi
noksokoivisto
et
al
aom
develop
children
confirm
human
metapneumoviru
upper
respiratori
tract
infect
find
strong
tempor
associ
human
metapneumoviru
aom
support
role
human
metapneumoviru
etiolog
aom
contrari
earlier
report
observ
associ
aom
rhinoviru
adenoviru
parainfluenza
activ
may
result
use
arima
model
assess
chang
activ
compar
previou
week
rather
absolut
number
case
method
power
disregard
stochast
depend
consecut
measur
exampl
high
burden
respiratori
viral
activ
today
tend
predict
high
activ
next
day
posit
autocorrel
arima
model
use
discrimin
natur
season
pattern
true
associ
howev
transform
data
stationari
seri
differenc
potenti
underestim
true
associ
virus
display
milder
season
fluctuat
rhinoviru
although
tempor
associ
prove
causal
relationship
mani
line
evid
suggest
direct
role
respiratori
virus
pathogenesi
aom
anim
studi
demonstr
synerg
respiratori
viral
infect
aom
chinchilla
follow
intranas
inocul
influenza
viru
pneumonia
pathogen
human
mani
studi
demonstr
presenc
respiratori
virus
mef
children
aom
antigen
detect
cultur
nucleic
acid
detect
furthermor
test
mef
nasopharyng
specimen
pcr
detect
virus
infrequ
detect
method
result
rhinoviru
picornavirus
human
metapneumoviru
coronaviru
increasingli
detect
mef
nasopharyng
specimen
children
aom
howev
prolong
nasopharyng
shed
rhinoviru
enteroviru
bocaviru
adenoviru
symptomat
asymptomat
children
limit
abil
determin
signific
detect
virus
aom
may
explain
part
absenc
epidemiolog
correl
rhinoviru
adenoviru
parainfluenza
aom
studi
sever
studi
shown
clear
benefit
influenza
vaccin
prevent
aom
reduct
aom
among
vaccin
recipi
utah
influenza
immun
coverag
among
children
month
year
age
accord
center
diseas
control
prevent
cdc
nation
immun
survey
data
suggest
effect
immun
strategi
potenti
decreas
burden
influenzaassoci
aom
studi
prevent
rsv
infect
passiv
immun
prophylaxi
intraven
rsvimmun
globulin
administ
prematur
infant
decreas
incid
aom
passiv
antibodi
therapi
expens
major
impact
burden
aom
vaccin
rsv
develop
moreov
preliminari
studi
antigen
epitop
human
metapneumoviru
may
lead
develop
human
metapneumoviru
vaccin
studi
subject
sever
limit
first
studi
design
demonstr
causal
relationship
individu
respiratori
virus
develop
aom
therefor
tempor
associ
observ
must
investig
clinic
studi
patient
level
unclear
lag
time
respiratori
viral
activ
aom
diagnos
differ
age
group
second
possibl
viral
test
may
like
order
subject
complain
earach
oppos
report
gener
viral
symptom
third
respiratori
viral
test
primarili
perform
among
inpati
present
emerg
depart
find
may
reflect
associ
respiratori
virus
includ
rhinovirus
aom
outpati
set
fourth
could
assess
immun
statu
children
includ
studi
vaccin
coverag
influenza
pneumococc
conjug
vaccin
rose
throughout
studi
period
compar
nation
rate
rate
measur
cdc
nation
immun
influenza
pneumococc
conjug
vaccin
compar
nation
rate
fifth
could
account
environment
factor
pollut
humid
temperatur
rainfal
may
repres
potenti
confound
factor
sixth
newli
describ
respiratori
virus
includ
nonsar
coronavirus
bocaviru
evalu
seventh
studi
base
singl
geograph
region
thu
find
may
generaliz
lastli
use
discharg
code
may
lead
misclassif
potenti
incorrectli
ascrib
case
aom
unabl
independ
assess
presenc
aap
diagnost
criteria
among
cohort
patient
howev
code
aom
report
agreement
manual
review
medic
record
aom
common
bacteri
infect
frequent
indic
antibiot
therapi
young
children
substanti
clinic
econom
impact
therefor
effort
prevent
aom
desper
need
studi
provid
evid
strong
tempor
relationship
aom
visit
among
children
rsv
human
metapneumoviru
influenza
activ
specul
meaning
reduct
overal
incid
aom
could
accomplish
effect
control
rsv
human
metapneumoviru
influenza
refer
web
version
pubm
central
supplementari
materi
tabl
autoregress
integr
move
averag
arima
analysi
circul
respiratori
virus
acut
otiti
media
